Patients with lymphoma can now access liquid biopsies
The ctDNA tests are being offered nationwide through charitable funding
Australian patients with T-cell lymphoma are among the first in the world to have access to circulating tumour DNA (ctDNA) tests, thanks to funding by two not-for-profit organisations.
The advance in genomic diagnostics helps to tailor treatment for patients with blood cancers, with a “meaningful outcome” yielded for 60% of patients tested to date, according to Dr Piers Blombery from the molecular haematology laboratory at the Peter MacCallum Cancer Centre in Melbourne.
